← All tickers

Is BHVN Worth Buying in 2026?

Biohaven Ltd.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Biohaven Ltd. (BHVN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+4.84% over 10 days); RSI 55 — healthy momentum range; 3-month momentum positive (+46.6%). Concerns: below the 50-day MA (medium-term momentum negative). Currently 25.4% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

BHVN is holding above its long-term 200-day MA ($11.38) but has slipped below the 50-day MA ($14.45), pointing to short-term weakness in an otherwise intact trend. An RSI of 54.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -5.7% compares to +20.5% for SPY (trailed the market by 26.1%). The current 25.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $9,435 today
vs. S&P 500 (SPY) — same period trailed market by 26.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($11.38)
✗Above 50-day MA ($14.45)
✓RSI(14) neutral zone (30–70) — currently 54.7
✗Positive return (-5.7%)
!Within 10% of period high (−25.4%)
Period Range $13.85
$7.48 $18.57
RSI (14) 54.7
0 · OversoldOverbought · 100

Key Metrics

Price$13.85
Period Return-5.7%
Period High$18.57
Period Low$7.48
Drawdown−25.4%
MA-50$14.45
MA-200$11.38
RSI (14)54.7
Avg Volume (30d)1.9M
vs. SPYtrailed by 26.1%
Return Rank#620 of 999

Trade BHVN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers